Report of the 2008-2009 Standing Committee on Advocacy.
作者信息
Kehrer James P, Brazeau Gayle A, DeGuire Nancy, Dopp Anna Legreid, Orrico Kathy B, Marchand Heidi C, Lang William G
机构信息
College of Pharmacy, Washington State University, Washington, USA.
出版信息
Am J Pharm Educ. 2009;73 Suppl(Suppl):S8. doi: 10.5688/aj7308s08.
Abstract
摘要
相似文献
1
Report of the 2008-2009 Standing Committee on Advocacy.
Am J Pharm Educ. 2009;73 Suppl(Suppl):S8. doi: 10.5688/aj7308s08.
2
Report of the 2010-2011 Standing Committee on Advocacy: Leveraging faculty engagement to improve public policy.
Am J Pharm Educ. 2011 Dec 15;75(10):S7. doi: 10.5688/ajpe7510S7.
3
AACP Strategic Engagement Committee Report: Report of the 2022-2023 Strategic Engagement Standing Committee.
Am J Pharm Educ. 2023 Aug;87(8):100557. doi: 10.1016/j.ajpe.2023.100557. Epub 2023 Jul 14.
4
Engaging in rapid cycle innovation.
Am J Pharm Educ. 2012 Apr 10;76(3):37. doi: 10.5688/ajpe76337.
5
Report of the 2019-2020 Strategic Engagement Standing Committee.
Am J Pharm Educ. 2020 Oct;84(10):ajpe8202. doi: 10.5688/ajpe8202.
6
Report of the 2010-2011 Academic Affairs Standing Committee.
Am J Pharm Educ. 2011 Dec 15;75(10):S12. doi: 10.5688/ajpe7510S12.
7
Report of the 2013-2014 AACP Standing Committee on Advocacy: improving advocacy through the use of implementation science concepts and frameworks.
Am J Pharm Educ. 2014 Dec 15;78(10):S20. doi: 10.5688/ajpe7810S20.
8
Expanding pharmacy services in a health system through partnership with a college of pharmacy.
Am J Health Syst Pharm. 2007 May 1;64(9):925-6. doi: 10.2146/ajhp060331.
9
Considering the Pharmacy Practice Model Initiative in college of pharmacy experiential-education curricula.
Am J Health Syst Pharm. 2015 Oct 1;72(19):1604-5. doi: 10.2146/ajhp150409.
10
The Report of the 2016-2017 Advocacy Standing Committee.
Am J Pharm Educ. 2017 Oct;81(8):S10. doi: 10.5688/ajpeS10.
本文引用的文献
1
The Master of Science in Clinical and Translational Research at the University of Connecticut.
Clin Transl Sci. 2008 Sep;1(2):92. doi: 10.1111/j.1752-8062.2008.00047.x.
2
Training clinical pharmaceutical scientists in today's highly competitive times: it's time to commit to change.
Pharmacotherapy. 2009 Feb;29(2):134-6; discussion 136-7. doi: 10.1592/phco.29.2.134.
3
Pharm.D.-only investigators are critical to the profession: let's preserve the fellowship as an equally important way to prepare future clinical pharmaceutical scientists: or the case against the "all-Ph.D.".
Pharmacotherapy. 2009 Feb;29(2):129-33. doi: 10.1592/phco.29.2.129.
4
The Pharm.D. investigator in clinical pharmacology: supply and demand.
Clin Pharmacol Ther. 2008 Oct;84(4):445-7. doi: 10.1038/sj.clpt.6100475.
5
Roles for pharmacy in combatting counterfeit drugs.
J Am Pharm Assoc (2003). 2008 Jul-Aug;48(4):e71-88; quiz e89-91. doi: 10.1331/JAPhA.2008.07069.
6
The meaning of translational research and why it matters.
JAMA. 2008 Jan 9;299(2):211-3. doi: 10.1001/jama.2007.26.
7
Opportunities for pharmacists in public health.
Am J Health Syst Pharm. 2007 Oct 1;64(19):2002-7. doi: 10.2146/ajhp070219.
8
A model for supporting and training clinical pharmaceutical scientist PhD students.
Am J Pharm Educ. 2007 Apr 15;71(2):32. doi: 10.5688/aj710232.
9
Time for quantitative clinical pharmacology: a proposal for a pharmacometrics curriculum.
Clin Pharmacol Ther. 2007 Jul;82(1):103-5. doi: 10.1038/sj.clpt.6100231. Epub 2007 May 9.
10
Direct-to-consumer print ads for drugs: do they undermine the physician-patient relationship?
J Fam Pract. 2005 Dec;54(12):1049-57.
Zotero 插件